Physician profile
Nicole Schecter
NPI 1376948190
$2,019.95
in general payments reported to CMS, 2019-2025
25 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $264 · 2022: $424 · 2023: $459 · 2024: $532 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,332.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $421.57 | 2022-2025 | |
| Antares Pharma, INC. | $393.27 | 2021-2025 | Xyosted |
| Astellas Pharma US INC | $196.94 | 2021-2024 | Xtandi |
| Medtronic, INC. | $115.09 | 2022-2025 | Interstim |
| Boston Scientific Corporation | $90.34 | 2021-2024 | Rezum Generator |
| Convatec INC. | $84.27 | 2021-2023 | |
| Tolmar Pharmaceuticals, INC. | $75.87 | 2021-2022 | |
| Halozyme INC | $68.44 | 2023 | |
| Sumitomo Pharma America, INC. | $57.55 | 2023 | Gemtesa |
| Janssen Biotech, INC. | $56.56 | 2024-2025 | Erleada |
| Coloplast Corp | $54.48 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $46.80 | 2022 | |
| Tolmar, INC. | $44.15 | 2023-2024 | |
| Pfizer INC. | $38.13 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $34.95 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $34.04 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Dendreon Pharmaceuticals LLC | $33.58 | 2021 | |
| Acerus Pharmaceuticals Corporation | $24.86 | 2022 | |
| Endo Pharmaceuticals INC. | $24.82 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $23.35 | 2025 | Bard Urinary Drainage Bag |
| Kowa Pharmaceuticals America, INC. | $23.06 | 2022 | |
| Urovant Sciences INC | $20.91 | 2022 | |
| Myriad Genetic Laboratories, INC. | $20.33 | 2023 | Prolaris |
| Abc Home Medical Supply, INC. | $19.31 | 2022 | |
| Allergan, INC. | $17.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Schecter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.